United States · Bill · S
S. 2089 (116th)
FDA Opioid Labeling Accuracy Act
Introduced
11 July 2019
Last action
11 July 2019 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Sen. Manchin, Joe, III [I-WV], Sen. Braun, Mike [R-IN]
Subjects
Healthcare
Source updated
21 April 2025
Summary
FDA Opioid Labeling Accuracy Act This bill restricts the labeling of certain opioid drugs recommending use for long-term chronic pain.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 July 2019
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
11 July 2019
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 11 July 2019 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 11 July 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 11 July 2019
Introduced in Senate
summary · EN · 11 July 2019
Sponsors
- Sen. Manchin, Joe, III [I-WV] · D · Sponsor
- Sen. Braun, Mike [R-IN] · R · Sponsor
- · sshr00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2089
- Open data entity: https://api.congress.gov/v3/bill/116/s/2089
- us · 116-s-2089 · source updated 21 April 2025